Hedge Fund - Woodline Partners
Regeneron Pharmaceuticals Inc. (REGN)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q2 (2024-06-30) | $191,179,204 | 1.82% | 181,897 | $969.40 |
| 2 | 2024 - Q1 (2024-03-31) | $164,202,719 | 1.51% | 170,602 | $950.88 |
| 3 | 2023 - Q4 (2023-12-31) | $149,388,346 | 1.62% | 170,090 | $823.50 |
| 4 | 2023 - Q3 (2023-09-30) | $112,393,293 | 1.31% | 136,572 | $785.91 |
| 5 | 2023 - Q2 (2023-06-30) | $34,247,053 | 0.4% | 47,662 | $771.00 |
| 6 | 2023 - Q1 (2023-03-31) | $126,800,936 | 1.72% | 154,321 | $754.21 |
| 7 | 2022 - Q4 (2022-12-31) | $115,072,605 | 1.53% | 159,493 | $737.86 |
| 8 | 2022 - Q3 (2022-09-30) | $129,065,000 | 1.8% | 187,357 | $629.39 |
| 9 | 2022 - Q2 (2022-06-30) | $31,207,000 | 0.48% | 52,792 | $650.01 |
| 10 | 2022 - Q1 (2022-03-31) | $73,679,000 | 1.19% | 105,494 | $632.65 |
| 11 | 2021 - Q4 (2021-12-31) | $56,992,000 | 0.81% | 90,246 | $614.83 |
| 12 | 2021 - Q3 (2021-09-30) | $45,900,000 | 0.74% | 75,846 | $620.82 |
| 13 | 2021 - Q2 (2021-06-30) | $43,487,000 | 0.81% | 77,859 | $506.62 |
| 14 | 2021 - Q1 (2021-03-31) | $87,956,000 | 1.95% | 185,899 | $486.87 |
| 15 | 2020 - Q4 (2020-12-31) | $9,761,000 | 0.25% | 20,204 | $539.80 |
| 16 | 2020 - Q3 (2020-09-30) | $0 | 0% | 0 | $606.33 |
| 17 | 2020 - Q2 (2020-06-30) | $19,160,000 | 0.75% | 30,722 | $567.62 |
| 18 | 2020 - Q1 (2020-03-31) | $13,417,000 | 0.95% | 27,477 | $412.49 |
The displayed share prices are average quarterly stock market prices.